Ainos Inc (AIMD): $ARMAQ Amarillo Biosciences is a special...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	51350
Boards Moderated	6
Alias Born	03/20/2012

StockMasterTalk

Re: None

Monday, 02/10/2014 12:19:58 PM

Monday, February 10, 2014 12:19:58 PM

$ARMAQ Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinical trials with a well-characterized therapeutic agent, interferon-alpha, in a proprietary low-dose oral formulation.

Disclaimer

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AIMD News

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/11/2024 08:10:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:20:42 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 09:10:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:11:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:11:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:10:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:10:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:10:37 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 02/15/2024 07:02:16 PM
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 02/08/2024 01:35:00 PM
Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024 • GlobeNewswire Inc. • 02/06/2024 02:51:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:10:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 11:54:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 11:50:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 11:50:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 11:50:45 PM
Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th • GlobeNewswire Inc. • 02/01/2024 01:35:00 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/29/2024 09:10:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:32:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:12:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:11:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:10:40 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/19/2023 05:15:08 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/15/2023 10:22:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:09:19 PM

More AIMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover